In continuation of corporate announcement dated November 07, 2025, Parmax Pharma has informed that the meeting of the Board of Directors of the Company which was supposed to be held on November 14, 2024, has been rescheduled on November 15, 2025 due to certain unavoidable reasons, unaudited financial results for quarter and half year ended on September 30, 2025 will be approved and considered at this meeting.
The above information is a part of company’s filings submitted to BSE.